# VALLON PHARMACEUTICALS INC (VLON)

> Institutional ownership reported to the SEC as of Q1 2023, from Form 13F filings. Source: https://holderbook.com/stocks/VLON/

- Reporting holders: 9
- Reported value: $37.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [TWO SIGMA SECURITIES, LLC](https://holderbook.com/funds/1450144-two-sigma-securities-llc/) | $8.2K | 22,708 | 0.0% | 2 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $7.8K | 21,569 | 0.0% | 8 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $6.8K | 18,921 | 0.0% | 3 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $5.5K | 15,109 | 0.0% | 1 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $4.0K | 11,095 | 0.0% | 1 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $4.0K | 11,907 | 0.0% | 6 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $1.1K | 2,919 | 0.0% | 2 |
| [Archer Investment Corp](https://holderbook.com/funds/1803804-archer-investment-corp/) | $36 | 100 | 0.0% | 2 |
| [WELLS FARGO & COMPANY/MN](https://holderbook.com/funds/72971-wells-fargo-company-mn/) | $21 | 58 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2023 | 9 | $37.4K |
| Q4 2022 | 13 | $88.5K |
| Q3 2022 | 7 | $74.0K |
| Q2 2022 | 8 | $141.0K |
| Q1 2022 | 12 | $765.0K |
| Q4 2021 | 12 | $2.9M |
| Q3 2021 | 11 | $2.8M |
| Q2 2021 | 9 | $3.1M |
| Q1 2021 | 9 | $2.4M |